This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies.Continue
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine.
This PIL is in PDF format and so you must have a PDF reader installed on your device to read it.
Text only version for the visually impaired
Below is a text only representation of the Patient Information leaflet. The original may contain images or tables and can be viewed in PDF format using the link above. This PIL may be available from the RNIB in large print, Braille or audio CD. For further information please call the RNIB Medicine Leaflet line on 0800 198 5000. The product code(s) for this leaflet is/are: EU/1/15/1002/001, EU/1/15/1002/002.
Lenvima 4mg and 10mg hard capsules
Package leaflet: Information for the user
LENVIMA 4 mg hard capsules
LENVIMA 10 mg hard capsules
lenvatinib
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
What is in this leaflet:
1. What LENVIMA is and what it is used for
2. What you need to know before you take LENVIMA
3. How to take LENVIMA
4. Possible side effects
5. How to store LENVIMA
6. Contents of the pack and other information
1. What LENVIMA is and what it is used for
What LENVIMA is
LENVIMA is a medicine that contains the active substance lenvatinib. It is used to treat progressive or advanced thyroid cancer in adults when radioactive iodine treatment has not helped to stop the disease.
How LENVIMA works
LENVIMA blocks the action of proteins called receptor tyrosine kinases (RTKs), which are involved in the development of new blood vessels that supply oxygen and nutrients to cells and help them to grow. These proteins can be present in high amounts in cancer cells, and by blocking their action LENVIMA may slow the rate at which the cancer cells multiply and the tumour grows and help to cut off the blood supply that the cancer needs.
2. What you need to know before you take LENVIMA
Do not take LENVIMA if:
Warnings and precautions
Talk to your doctor before taking LENVIMA if you:
Before taking LENVIMA, your doctor may carry out some blood tests, for example to check your blood pressure and your liver or kidney function and to see if you have low levels of salt and high levels of thyroid stimulating hormone in your blood. Your doctor will discuss the results of these tests with you and decide whether you can be given LENVIMA. You may need to have additional treatment with other medicines, to take a lower dose of LENVIMA, or to take extra care due to an increased risk of side effects.
If you are not sure talk to your doctor before taking LENVIMA.
Children and adolescents
LENVIMA is not recommended for use in children and adolescents. The effects of LENVIMA in people younger than 18 years old are not known.
Other medicines and LENVIMA
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes herbal preparations and medicines without a prescription.
Contraception, pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
LENVIMA may cause side effects that can affect your ability to drive or use machines. Avoid driving or using machines if you feel dizzy or tired.
3. How to take LENVIMA
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
How much to take
Taking this medicine
How long to take LENVIMA
You will usually carry on taking this medicine as long as you are getting benefit.
If you take more LENVIMA than you should
If you take more LENVIMA than you should, talk to a doctor or pharmacist straight away. Take the medicine pack with you.
If you forget to take LENVIMA
Do not take a double dose (two doses at the same time) to make up for a forgotten dose.
What to do if you forget to take your dose depends on how long it is until your next dose.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine.
Tell your doctor straight away if you notice any of the following side effects - you may need urgent medical treatment:
Tell your doctor straight away if you notice any of the side effects above.
Other side effects include:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Not Known (the following side effects have been reported since the marketing of LENVIMA but the frequency for them to occur is not known)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store LENVIMA
6. Contents of the pack and other information
What LENVIMA contains
What LENVIMA looks like and contents of the pack
Marketing Authorisation Holder
Manufacturer
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
This leaflet was last revised in 03/2017.
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.